🇺🇸 FDA
Pipeline program

Surgery

199/11667

Phase 2 other active

Quick answer

Surgery for Spastic Diplegia is a Phase 2 program (other) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Spastic Diplegia
Phase
Phase 2
Modality
other
Status
active

Clinical trials